Cell Gene Therapy Supply Chain (MP2)

Over the course of the last decade, there has been an increased emphasis on research and development into cell, gene and immunotherapy treatments.  The outlook is positive, due in part to advancements in science and the availability of more sophisticated diagnostic tools, which are giving the medical community a better understanding of the human genome and making it easier to detect genetic mutations affecting individual patients. Come to this mini presentation to learn about the challenges of cell & gene therapies, the challenges of their unique supply chains and how to overcome them.